| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/29/2001 | WO2001022087A1 Marking of products with electroactive compounds |
| 03/29/2001 | WO2001022086A1 A high-throughput system for evaluating the clinical utility of molecular targets in tissue samples |
| 03/29/2001 | WO2001022085A1 Method of fractional measurement of soluble cd14 protein |
| 03/29/2001 | WO2001022084A2 Spr identification of inhibitors of receptor-ligand interactions |
| 03/29/2001 | WO2001022083A2 Method for identifying mhc-restricted antigens |
| 03/29/2001 | WO2001022082A1 Method to study insulin action |
| 03/29/2001 | WO2001022081A1 Animal carcase analysis |
| 03/29/2001 | WO2001022064A1 Fluorescent particle imaging device |
| 03/29/2001 | WO2001022053A1 Sealless die assembly for viscoelastic measuring apparatus |
| 03/29/2001 | WO2001022051A1 Standards for monitoring assaying of precious metals |
| 03/29/2001 | WO2001022050A1 Method and system for extracting, analysing and measuring constituents transported by a bore fluid |
| 03/29/2001 | WO2001021951A1 METHOD FOR MONITORING THE FUNCTIONING OF AN NOx SENSOR ARRANGED IN AN EXHAUST GAS CHANNEL OF AN INTERNAL COMBUSTION ENGINE |
| 03/29/2001 | WO2001021838A2 Three-dimensional microarray system for parallel genotyping of single nucleotide polymorphisms |
| 03/29/2001 | WO2001021831A1 Method for identifying novel genes involved in the regulation of angiogenesis, study of said genes and use thereof for therapeutic purposes |
| 03/29/2001 | WO2001021830A1 Nuclease inhibitor cocktail |
| 03/29/2001 | WO2001021828A1 A pcam-1 marker protein, nucleic acid sequences encoding pcam-1 and immunoassays for detection of pcam-1 |
| 03/29/2001 | WO2001021827A1 Small volume biosensor for continuous analyte monitoring |
| 03/29/2001 | WO2001021826A2 Detecting the presence of the pyruvate kinase isoenzyme in feces |
| 03/29/2001 | WO2001021815A1 Checkpoint gene associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021814A1 Heparanase-2, a member of the heparanase protein family |
| 03/29/2001 | WO2001021812A1 Phosphatases which activate map kinase pathways |
| 03/29/2001 | WO2001021804A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 03/29/2001 | WO2001021799A1 Traf4 associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021797A1 Rgs10b, a g-protein regulator expressed in osteoclasts |
| 03/29/2001 | WO2001021796A2 Gl50 molecules and uses therefor |
| 03/29/2001 | WO2001021793A1 p21Cip1 REMEDIES FOR RHEUMATISM |
| 03/29/2001 | WO2001021791A2 Stargazin-like neuronal ca2+-channel gamma subunit polypeptides |
| 03/29/2001 | WO2001021788A1 MAST CELL-SPECIFIC SIGNAL TRANSDUCING MOLECULES AND cDNAS THEREOF |
| 03/29/2001 | WO2001021784A2 Pcna-associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021771A2 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 03/29/2001 | WO2001021767A2 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
| 03/29/2001 | WO2001021663A1 Pcna associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021662A1 Signal sequences for the production of leu-hirudine via secretion by e. coli in a culture medium |
| 03/29/2001 | WO2001021658A1 32 human secreted proteins |
| 03/29/2001 | WO2001021654A2 Syk kinase-associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021652A1 Methods for identifying an agent that corrects defective protein folding |
| 03/29/2001 | WO2001021634A1 Benzimidazole derivatives and combinatorial libraries thereof |
| 03/29/2001 | WO2001021632A1 Method for nucleic acid isolation and kit |
| 03/29/2001 | WO2001021326A1 Water-soluble coating agents bearing initiator groups and coating process |
| 03/29/2001 | WO2001021220A2 Bioprosthetic heart valves |
| 03/29/2001 | WO2001021215A1 Cell based assay |
| 03/29/2001 | WO2001021205A1 Coupling factor 6 inhibitor and potentiator and use thereof |
| 03/29/2001 | WO2001021204A1 Therapeutic uses of m3 polypeptide |
| 03/29/2001 | WO2001021202A2 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 03/29/2001 | WO2001021193A1 Hybrid peptides modulate the immune response |
| 03/29/2001 | WO2001021183A1 Solid phase assay |
| 03/29/2001 | WO2001021136A2 Compositions and methods for improved detection and classification of neoplasms |
| 03/29/2001 | WO2001021009A2 Standardized functional food products |
| 03/29/2001 | WO2001020998A1 Drug discovery using gene expression profiling |
| 03/29/2001 | WO2001020977A1 Novel animal model of alzheimer disease with amyloid plaques and mitochondrial dysfunctions |
| 03/29/2001 | WO2001020973A2 Plant genes for sensitivity to ethylene and pathogens |
| 03/29/2001 | WO2001002851A8 Method for screening targeting dds preparation |
| 03/29/2001 | WO2001002557A8 Neurotrophic factor receptor |
| 03/29/2001 | WO2001000843A3 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 03/29/2001 | WO2000077026A8 49 human secreted proteins |
| 03/29/2001 | WO2000065366A8 Nmr-method for determining the risk of developing type 2 diabetes |
| 03/29/2001 | WO2000061067A3 Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein |
| 03/29/2001 | WO2000057188A3 Proteins associated with mammary cancer and method for detecting same |
| 03/29/2001 | WO2000034779A9 Immunoisolation of caveolae |
| 03/29/2001 | WO2000034436A9 Facs assisted methods for introducing individual chromosomes into cells |
| 03/29/2001 | WO2000032775A9 Pth1r and pth3r receptors |
| 03/29/2001 | WO2000031290A9 Methods and compositions for pain management |
| 03/29/2001 | WO2000023615A3 Method for extracting quantitative information relating to an influence on a cellular response |
| 03/29/2001 | WO1999050282A3 Peptides for the treatment, prophylaxis, diagnosis and monitoring of autoimmune diseases |
| 03/29/2001 | WO1999013083A9 Method and means for modulating plant cell cycle proteins and their use in controlling plant cell growth |
| 03/29/2001 | US20010000078 Diagnostic modified-nucleoside detection assay |
| 03/29/2001 | US20010000075 Neurotactin and uses therefor |
| 03/29/2001 | DE19947387A1 Soil sample analysis method dissolves out nitrogen to stable intermediate solution prevents errors due to changes in transit |
| 03/29/2001 | DE19946296A1 Multiplex-PCR zum Nachweis von EHEC-Infektionen Multiplex PCR for detection of EHEC infections |
| 03/29/2001 | DE19945947A1 Nachweis des Pyruvatkinase-Isoenzyms Proof of pyruvate kinase isoenzyme |
| 03/29/2001 | DE19945828A1 Analyzing element for quantifying analytes in a fluid comprises a sample reception zone and analyzing zones on different layers |
| 03/29/2001 | DE19945553A1 Detecting Meticillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci comprises using a flow-through cytometer and fluorescence readings |
| 03/29/2001 | DE19945374A1 Verfahren zur Funktionsüberwachung eines in einem Abgaskanal einer Verbrennungskraftmaschine angeordneten NO¶x¶-Sensors A method for functional monitoring of a arranged in an exhaust passage of an internal combustion engine NO¶x¶ sensor |
| 03/29/2001 | DE19944870A1 Signalsequenzen zur Herstellung von Leu-Hirudin über Sekretion durch E. coli in das Kulturmedium Signal sequences for preparing Leu-hirudin by E. coli via secretion into the culture medium |
| 03/29/2001 | DE19944226A1 Verfahren zum Nachweis von oxidierten Formen der löslichen Guanylatzyklase und Verfahren zum Screening nach Aktivatoren der löslichen Guanylatzyklase mit oxidiertem Hämeisen Method for the detection of oxidized forms of the soluble guanylate cyclase and method of screening for activators of soluble guanylate cyclase with oxidized heme iron |
| 03/29/2001 | DE19941586A1 High-integrity breathalyzer apparatus suitable for vehicle immobilization in event of unacceptable result, includes sensors for carbon dioxide, alcohol and pressure profile |
| 03/29/2001 | CA2387695A1 A novel member of the heparanase protein family |
| 03/29/2001 | CA2387693A1 Method for monitoring treatment with a parathyroid hormone |
| 03/29/2001 | CA2385879A1 Traf4 associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | CA2385851A1 Three-dimensional microarray system for parallel genotyping of single nucleotide polymorphisms |
| 03/29/2001 | CA2385849A1 Medical applications of orthogonal polarization spectral imaging |
| 03/29/2001 | CA2385783A1 A pcam-1 marker protein, nucleic acid sequences encoding pcam-1 and immunoassays for detection of pcam-1 |
| 03/29/2001 | CA2385697A1 Method for identifying novel genes involved in the regulation of angiogenesis, study of said genes and use thereof for therapeutic purposes |
| 03/29/2001 | CA2385658A1 Hybridization self-recognition probe |
| 03/29/2001 | CA2385552A1 Phosphatases which activate map kinase pathways |
| 03/29/2001 | CA2385480A1 32 human secreted proteins |
| 03/29/2001 | CA2385460A1 Rgs10b, a g-protein regulator expressed in osteoclasts |
| 03/29/2001 | CA2385428A1 Novel pcna-associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | CA2385425A1 Pcna associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | CA2385377A1 Method to identify compounds useful in the therapy of bone disorders |
| 03/29/2001 | CA2385334A1 Novel syk kinase-associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | CA2385264A1 Method for determining the fertility of mammals, especially of humans |
| 03/29/2001 | CA2385257A1 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 03/29/2001 | CA2385235A1 Checkpoint gene associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | CA2384928A1 Method for identifying compounds useful in the therapy of bone disorders |
| 03/29/2001 | CA2384865A1 Novel animal model of alzheimer disease with amyloid plaques and mitochondrial dysfunctions |
| 03/29/2001 | CA2384340A1 Animal carcase analysis |
| 03/29/2001 | CA2383838A1 Method of fractional measurement of soluble cd14 protein |
| 03/29/2001 | CA2383629A1 Hybrid peptides modulate the immune response |
| 03/29/2001 | CA2383598A1 Therapeutic uses of m3 polypeptide |